Insulet
PODD
#1280
Rank
S$22.49 B
Marketcap
S$319.50
Share price
-2.08%
Change (1 day)
-15.75%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: S$22.49 Billion

As of February 2026 Insulet has a market cap of S$22.49 Billion. This makes Insulet the world's 1280th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026S$22.49 B-13.78%
2025S$26.08 B3.19%
2024S$25.27 B26.33%
2023S$20.01 B-26.99%
2022S$27.40 B10.48%
2021S$24.80 B11.27%
2020S$22.29 B54.1%
2019S$14.46 B125.58%
2018S$6.41 B19.44%
2017S$5.37 B71.47%
2016S$3.13 B2.81%
2015S$3.04 B-11.1%
2014S$3.42 B32.85%
2013S$2.57 B105.53%
2012S$1.25 B8.58%
2011S$1.15 B27.39%
2010S$0.90 B19.87%
2009S$0.75 B167.46%
2008S$0.28 B-67.32%
2007S$0.86 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Insulet was reported to be:

S$22.47 Billion
by Nasdaq info icon info icon
S$22.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$714.25 B 3,075.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$241.31 B 972.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$168.31 B 648.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$1.144 T 4,986.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
S$1.67 B-92.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$4.73 B-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$35.72 B 58.84%๐Ÿ‡บ๐Ÿ‡ธ USA